Diabetes Clinical Trials in San Diego

Showing 261-280 of 291 trials

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

NCT00143247

This is a long-term safety study for Phase 2 subjects who choose to remain on Exubera® (inhaled insulin).

Pfizer173 participantsStarted Mar 2003

San Diego, California, United States • New Haven, Connecticut, United States • Miami, Florida, United States +9 more locations

COMPLETEDPHASE26.9 miles

A Study for Patients With Type 2 Diabetes Mellitus

NCT00804986

A multicenter, multinational, randomized,double-blind, placebo-controlled study in patients with Type 2 Diabetes Mellitus (T2DM). Patients with inadequate glycemic control using diet and exercise alone, or in combination with metformin, will be enrolled. The primary objective of this study is to test the hypothesis that LY2428757 given to patients with T2DM inadequately controlled with diet and exercise alone, or metformin monotherapy, produces a significant decrease in the mean hemoglobin A1c (HbA1c) from baseline to endpoint at 12 weeks as compared to placebo. Trial consists of 12 weeks of double-blind treatment and 4-week safety follow-up.

Diabetes Mellitus, Type 2

Eli Lilly and Company247 participantsStarted Dec 2008

Bermuda Dunes, California, United States • Chula Vista, California, United States • Huntington Beach, California, United States +57 more locations

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

A Study for Patients With Type 2 Diabetes Mellitus

Diabetes Trials in Other Cities

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics After High Single Ascending Oral Doses of AZD1656 in T2DM Patients

Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

Diabetes Control and Complications Trial (DCCT)

Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study

GALLANT 6 Tesaglitazar vs. Pioglitazone

Effect of South Beach Diet (SBD™) Using SBD™ Products Compared to the American Diabetic Association (ADA) Diabetes Meal Plan on Body Weight and Satiety in Diabetic Women

Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

DPBRN Blood Sugar Testing in Dental Patients

GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate

Other Conditions in San Diego